NTES trades against a final fair-value range of $139.31-$218.83, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $139, high $219, with mid-point at $178.
Analysé: 2026-05-20·Prochaine mise à jour: 2026-08-20·Methodology v2.4·Data cut-off:·Quality gate: pass·Sources: all material sources passed deterministic freshness/provenance gates·Review: automated·Archetype: Mature compounder
Trades below fair value with a meaningful cushion to the midpoint.
Fair value
$178
Margin of safety
+35.6%
Confidence
82/100
Moat
8/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$114.49Price
Low $139.31
Mid $177.78
High $218.83
NTES trades against a final fair-value range of $139.31-$218.83, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Proprietary IP portfolio with 15+
Proprietary IP portfolio with 15+ year lifecycle duration
Massive R&D scale supporting high-fidelity
Massive R&D scale supporting high-fidelity production
Bull thesis
Value: Trading at 11.2x fwd P/E vs 20x global peers
Based on our latest analysis, NTES looks meaningfully undervalued. The current price is $114 versus a composite fair-value midpoint of $178 (range $139–$219), which implies roughly 55.3% upside to the midpoint.
Our composite fair-value range for NTES is $139–$219, with a midpoint of $178. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for NTES's archetype.
Our current rating for NTES is Strong Buy with a confidence score of 82/100. NTES is rated Strong Buy at $114.49 versus the reconciled fair value midpoint of $177.78, implying +55.28% upside/downside. Confidence is separately disclosed at 82/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for NTES are: Regulatory Monetization Freeze; Global Pipeline Failure; Cash Seizure/Restricted Access. The single biggest risk is The biggest risk is that the bear-case drivers materialize: growth slows, margins compress, or competitive pressure reduces the fair-value range.
Our current rating for NTES is Strong Buy, issued with a confidence score of 82/100 and a moat score of 8/10. The rating reflects the composite fair-value range ($139–$219) versus the current price of $114.
NTES is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for NTES.